Influence of Rivaroxaban Compared to Vitamin K Antagonist Treatment Upon Development of Cardiovascular Calcification in Patients With Atrial Fibrillation and/ or Pulmonary Embolism (IRIVASC- Trial)
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2019
Price : $35 *
At a glance
- Drugs Rivaroxaban (Primary) ; Phenprocoumon
- Indications Pulmonary embolism; Stroke
- Focus Adverse reactions
- Acronyms IRIVASC
- 20 Aug 2019 Planned End Date changed from 1 Dec 2019 to 1 Mar 2020.
- 20 Aug 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2020.
- 25 Mar 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Mar 2019.